Target intelligence / Profile preview

Transmembrane protein 16A calcium-activated chloride channel (TMEM16A)

Target
TMEM16A
Molecular classification
Ion channel, Chloride channel, Transmembrane protein
01

Overview

Transmembrane protein 16A calcium-activated chloride channel (TMEM16A) is a widely expressed, dimeric ion channel that is directly activated by increases in intracellular calcium, coupling cellular calcium signals to chloride ion flux across membranes[1][7][10]. TMEM16A plays essential roles in regulating epithelial fluid and mucous secretion, airway hydration, smooth and gastrointestinal muscle contractility, neuronal excitability, and sensory transduction[2][3][4][6][7][8][9]. Dysfunction or overexpression of TMEM16A is implicated in diseases such as asthma, cystic fibrosis, hypertension, inflammatory disorders, and several cancers, notably as a driver in some gastrointestinal stromal tumors[4][5][9]. The protein’s structure features two identical subunits, each forming a chloride conducting pore gated by calcium binding; it is subject to regulation by membrane lipids, phosphorylation, and protein-protein interactions[1][2][5][10]. Due to its contributions to various physiological processes and disease mechanisms, TMEM16A is considered a promising but challenging therapeutic target for drug development[5].

Other names
Anoctamin-1Ano1Calcium-activated chloride channel 1CaCCTransmembrane protein 16ATMEM16A channel
02

Mechanism of action

Inhibition of chloride channel function (inhibitors) Activation of chloride channel function (activators)

03

Biological functions

Epithelial fluid secretionRegulation of neuronal excitabilitySmooth muscle contractionSensory transductionRegulation of gastrointestinal motilityCell proliferation
04

Disease associations

CancerInflammationCardiovascular diseaseRespiratory disease (e.g., cystic fibrosis, asthma)Gastrointestinal disorders (motility, secretion)
05

Safety considerations

Broad tissue distribution raises potential for off-target effectsModulation may disrupt epithelial, cardiovascular, and gastrointestinal physiologyRisk of altered fluid balance, smooth muscle dysfunction, or abnormal neuronal excitability
06

Interacting drugs

Niclosamide

5 more in the full profile.

07

Biomarkers

TMEM16A (Ano1) overexpression in certain cancers (e.g., gastrointestinal stromal tumors)Expression as biomarker for airway secretory function

Beyond the preview

Go deeper on Transmembrane protein 16A calcium-activated chloride channel (TMEM16A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 16A calcium-activated chloride channel (TMEM16A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call